Literature DB >> 1493993

Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients.

N Somolinos, R Arranz, M C Del Rey, M L Jiménez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1493993     DOI： 10.1093/jac/30.5.730

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Authors:  W V Kern; K Klose; A S Jellen-Ritter; M Oethinger; J Bohnert; P Kern; S Reuter; H von Baum; R Marre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.

Authors:  Bridgette L Therriault; John W Wilson; Jason N Barreto; Lynn L Estes
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

3.  Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.

Authors:  Michele Pohlen; Julia Marx; Alexander Mellmann; Karsten Becker; Rolf M Mesters; Jan-Henrik Mikesch; Christoph Schliemann; Georg Lenz; Carsten Müller-Tidow; Thomas Büchner; Utz Krug; Matthias Stelljes; Helge Karch; Georg Peters; Hans U Gerth; Dennis Görlich; Wolfgang E Berdel
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

Review 4.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

5.  Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.

Authors:  Koichi Tanimoto; Haruyoshi Tomita; Shuhei Fujimoto; Katsuko Okuzumi; Yasuyoshi Ike
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

6.  Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials.

Authors:  H Imran; I M Tleyjeh; C A S Arndt; L M Baddour; P J Erwin; C Tsigrelis; N Kabbara; V M Montori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-16       Impact factor: 3.267

Review 7.  Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.

Authors:  Nicole Skoetz; Julia Bohlius; Andreas Engert; Ina Monsef; Oliver Blank; Jörg-Janne Vehreschild
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.